Gunning Group recognized with Connaught Innovation Award!
The Gunning Group has received a Connaught Innovation Award to support the development of HDAC2 inhibitors for the treatment of Duchenne Muscular Dystrophy (DMD)
top of page
Featured Posts
Recent Posts
Archive
Search By Tags
Follow Us
bottom of page
Comentarios